Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Introduction. In 1980 Furchgort and Zawadzki [1] showed that the vascular endothelium is capable of releasing a potent short-acting vasodilating substance in response to the application of acetylcholine (ACh). This substance, initially defined as endothelium-derived relaxing factor, was subsequently identified with nitric oxide (NO) [2]. Since then a wealth of research has demonstrated the involvement of this molecule not only in the regulation of vascular resistance but also in immunological processes, neuronal transmission, platelet function, growth of smooth muscle cells and cardiac mechanical and electrophysiological properties [3-5].


Journal article


Blood Press Monit

Publication Date





125 - 131